Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ACA, AML, arithmetic, ATM, Berlin, Binomial, Black, bleeding, BMS, bought, brochure, carcinogenicity, chose, chosen, Cogle, compliant, composition, congressional, consecutive, constrained, conversion, convert, convertible, CRADA, curtail, customary, cytologically, deadline, deficient, delist, delisted, delisting, die, died, downstream, drop, duty, ease, environment, epithelial, evidenced, explanatory, formula, France, GCIG, Germany, goal, GOG, grace, Hearing, histological, histologically, Howson, imposition, inability, inconclusive, indemnification, Inter, interfere, introduction, Italy, journalBloodin, lineage, lowest, matter, McNicoll, MDS, mediated, Medicaid, Milan, minitab, MLV, modulating, mutagenicity, myelodysplastic, NCI, occupied, open, ordinary, OXGND, path, pharmacokinetic, PIPE, pretreated, promulgation, proximity, quinine, rarity, rat, ratchet, reaction, reactive, redirected, referenced, regain, repeal, retention, revert, screened, SeeSymphony, seventeen, spanned, spent, split, statute, subgroup, suspected, symposium, Tamar, teratogenicity, ticker, timeframe, Transactionabove, Treaty, Trust, unanimously, underwriter, uninsured, unpredictable, viability, Vlak, web
Removed:
abbreviated, account, accrual, adding, amine, Antisoma, area, assist, assistance, Avenue, ban, bioavailability, biotechnological, Bristol, broaden, certification, challenging, commence, complying, comprised, compulsory, continual, cornea, correct, court, deriving, discrete, disputed, disrupt, dissemination, dossier, draft, drafted, drawn, economic, effectively, electronic, element, employment, encountered, entering, establishment, eventually, expansion, expensive, experiencing, false, feasible, Finally, footnote, formulary, front, hiring, impossible, indirect, Intracel, invalidity, invention, ion, lawfully, leaflet, legislation, lift, manage, measured, metabolized, mitigation, Modernization, necessarily, negotiated, negotiating, newly, noted, online, optional, outpatient, package, Park, passage, passed, passing, people, pharmacoeconomic, pharmacy, pipeline, postmarket, premium, prescription, privately, promoted, propose, prospectively, reauthorized, registry, regulated, reinterpreted, repeated, replace, reviewed, revised, safer, salt, sampling, Science, senior, setting, shorter, signature, standardized, strictly, sublease, sublicense, synthetic, television, thereon, tier, unannounced, unapproved, undiscovered, version, Watertown, website, withdraw, world
Filing tables
Filing exhibits
Related press release
OTLC similar filings
Filing view
External links
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of OXiGENE, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2010 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 16, 2011 | /s/ Peter J. Langecker | |||
Peter J. Langecker, Chief Executive Officer | ||||
Dated: March 16, 2011 | /s/ James B. Murphy | |||
James B. Murphy, Chief Financial Officer | ||||